Cardiovascular and Soft Tissue Repair Patches Market Size (2024 - 2029)

Cardiovascular & Soft Tissue Repair Patches Market Analysis

The Cardiovascular and Soft Tissue Repair Patches Market is expected to register a CAGR of 8% during the forecast period.

The early phase of the COVID-19 pandemic significantly impacted the market, as the strict lockdowns and government regulations slowed the spread of COVID-19. This resulted in a reduction in the number of clinical procedures. During the pandemic, people did not visit hospitals or clinics for cardiovascular procedures due to lockdown restrictions. According to an article published by PubMed in May 2021, a study performed in the United Kingdom showed that the number of cardiac procedures has significantly declined across England during the COVID-19 pandemic, with a deficit of more than 45,000 procedures, without an increase in the risk of mortality for most cardiac procedures were not performed during the pandemic, and this might impact long-term morbidity and mortality. Also, according to an article published by PubMed Central in March 2022, a study in the United States showed that the adult cardiac surgery volume decreased significantly during the pandemic. And, according to an article published by PubMed Central in September 2021, in the reopening phase after the pandemic an incomplete recovery to pre-surge levels of hospitalizations and cardiovascular procedures was observed, but it is expected to eventually rebound to meet or exceed pre-COVID-19 levels. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; currently, the market has gained traction as the pandemic has subsided, and it is expected to have a stable growth during the forecast period of the study.

Further, the increasing technological advancements, increasing prevalence of congenital heart diseases, and increasing R&D expenditure attribute to the growth of the market. In addition, the rising prevalence of congenital atrial and ventricular septal defects and growing inclination towards minimally invasive procedures also result in high adoption of the patches and trigger the growth of the market. Moreover, an increase in the prevalence of congenital diaphragmatic hernias, and inguinal hernias is also promoting the growth of the market as these patches are used in the treatment of these disorders through tissue repairing procedures. As per the data by NCBI in August 2022, inguinal hernia affects nearly 25% of men and less than 2% of women over their lifetime, and males account for about 90% of all inguinal hernia cases. The increasing prevalence of inguinal hernia is expected to increase the usage of soft tissue repair patches. Furthermore, increasing collaboration between manufacturers and research organizations, government initiatives associated with cardiac treatments, and the development of novel technologies are a few more factors driving the growth of the cardiovascular and soft tissue repair patches market. However, the stringent regulatory framework is likely to impede market growth.

Cardiovascular & Soft Tissue Repair Patches Industry Segmentation

Cardiovascular and soft tissue repair patches are used for tissue repair procedures such as soft tissue repairs, vascular repair, and reconstruction. The cardiovascular and soft tissue repair patches market is segmented by raw material (biomaterial and tissue engineered material, ePTFE), by application (cardiac repair, soft tissue repair, vascular repair & reconstruction), and by geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major region, globally. The report offers the value (in USD million) for the above segments.